Aethlon Medical Shares Are Trading Higher After the Company Announced That It Received Granted Ethics Committee Approval for Hemopurifier Cancer Treatment. Also, the European Commission Recommended Extending the Indication of the Smallpox and Mpox...

Aethlon Medical股票交易上漲，因該公司宣佈獲得了Hemopurifier癌症治療的倫理委員會批准。此外，歐洲委員會建議將天花和M疫苗的適應症擴展到青少年。

Benzinga · 09/20 19:50

Aethlon Medical Shares Are Trading Higher After the Company Announced That It Received Granted Ethics Committee Approval for Hemopurifier Cancer Treatment. Also, the European Commission Recommended Extending the Indication of the Smallpox and Mpox Vaccine to Adolescents.

aethlon medical股票交易上漲，因爲該公司宣佈 Hemopurifier 癌症治療已獲得倫理委員會的批准。此外，歐盟委員會建議將天花和MPOX疫苗的適應症擴展到青少年。

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。